All News #Library
Biotech
CANbridge Pharmaceuticals to Present Fabry Disease Gene Therapy Abstract
25 Oct 2023 //
PR NEWSWIRE
CANbridge Announces Enrollment Reached in Core Part of The CAN103 Phase 2 Trial
16 Oct 2023 //
PR NEWSWIRE
CANbridge to Continue CAN008 Phase 2 Trial in GBM in China
03 Jul 2023 //
BUSINESSWIRE
CANbridge Reports Positive Preliminary Data in the Omoprubart Phase 1b Trial
26 Jun 2023 //
BUSINESSWIRE
CANbridge Reports +ve Preliminary Data in the Omoprubart Ph1b Trial PNH in China
26 Jun 2023 //
BUSINESSWIRE
CANbridge and CAN203 Improves Lifespan and Motor Function
17 May 2023 //
BUSINESSWIRE
CANbridge Pharmaceuticals Appoints Jason West VP, Head of Gene Therapy
04 May 2023 //
BUSINESSWIRE
CANbridge-UMass Chan Medical School SMA Gene Therapy Data ASGCT
02 May 2023 //
BUSINESSWIRE
CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of GBM
27 Mar 2023 //
BUSINESSWIRE
Data from CANbridge CAN008 Ph1/2 Trial in Shows 67% Five-Year Survival Rate
16 Mar 2023 //
BUSINESSWIRE
First Patient Dosed in CANbridge Pharmaceuticals CAN103 Phase 2 Trial
18 Jan 2023 //
BUSINESSWIRE

Market Place
Sourcing Support